GestaCare T 30 Capsules is an international reference supplement, specifically developed without iodine for women who cannot take iodine supplements, to be used from the moment the couple wants to get pregnant.

Supplementation with GestaCare T aims to eliminate the risk of deficiency of micronutrients essential for good fetal development and maternal health. Taking GestaCare T should be started as early as possible (preferably before the start of pregnancy) and continued throughout the entire pregnancy.

Supplementation during pregnancy is decisively associated with the prevention of birth defects and the reduction of preterm delivery. The risk of a micronutrient deficiency, when occurring during pregnancy, can have maternal-fetal repercussions that are sometimes irreversible and with subclinical manifestations.

GestaCare T has the latest generation folic acid in its composition, Quatrefolic (see more information below). With Ginger Nauseastop® in its formulation, in agreement with the main international study organizations, which advocate the safety and pertinence of its use in nausea induced by pregnancy (see more information below).

GestaCare T contains a state-of-the-art formulation, specially developed to offer the woman who wants to get pregnant or is already pregnant the best tolerability in a supplement, in such a special period of her life.

According to national and international medical recommendations, it is essential to accompany your pregnancy by taking a set of essential micronutrients for maternal health and fetal development.

GestaCare T is a pharmaceutical product of international reference, specifically developed for the period of pregnancy for women who cannot take iodine, for use from the moment the couple wants to become pregnant.

Quatrefolic Folate (Folic Acid), Omega 3 (Plant DHA), Vitamin D and B12, Iron, among many other active components of GestaCare T are decisively associated with the prevention of birth defects, the reduction of preterm births and of other obstetric complications.

GestaCare T aims to eliminate the risk of deficiency of micronutrients essential for good fetal development and maternal health.

The risk of deficiency, when occurring during pregnancy, may have maternal-fetal repercussions that are sometimes irreversible and with subclinical manifestations.

GestaCare T has already been developed in accordance with the most recent international recommendations and therefore contains Quatrefolic Folate (Folic Acid) of the latest generation in its composition.